Cambridge researchers have discovered that an existing therapy which boosts protective immune cells in people who recently ...

An ex-banker at Jefferies Financial Group Inc.’s UK arm pleaded not guilty to an insider dealing charge brought by the markets watchdog.

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...

Non-dilutive public-private funded trial with NIAID STTR & Mary Gooze Clinical Trial and Translation AwardExpands iNKT ...

By using a patient's DNA to craft personalized drug treatments, doctors can increase the efficacy and better the outcomes of ...

Medical Devices includes a session from a regulatory expert on how companies can align their research between regions.

Reported 12-month overall survival (OS) in Phase 2a clinical trial nearly double the benchmark from pivotal study of standard ...

Bobosher Sharipov, who had worked at Jefferies Financial Group's (JEF) U.K. arm, pleaded not guilty, to an insider trading ...

After unsheathing just a few months ago, Ollin Biosciences’ next-gen bispecific antibody cleared more disease faster than ...

W.L. Gore & Associates announced today that the FDA approved its Viabahn Fortegra venous stent, formerly known as Viafort.

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show that cancer drug ...

Gore & Associates announced FDA approval of the Gore Viabahn Fortegra venous stent—previously known as the Gore Viafor ...